Biological Technology Company - Hui Bio-B First Day Listing, Stock Price Rises 168.53%
Graton August 11th | Hui Bio-B (2627.HK) today listed its shares on the Hong Kong market for the first time, with an initial rise of 168.53% to HK$34.64. Hui Bio was founded in 2015 and is a biologica
Graton August 11th | Hui Bio-B (2627.HK) today listed its shares on the Hong Kong market for the first time, with an initial rise of 168.53% to HK$34.64. Hui Bio was founded in 2015 and is a biological technology company focused on the research, development, manufacturing, and commercialization of human vaccines. The company currently has two major core products garnering attention: one is already listed four-strain influenza virus subunit vaccine, and another is an ongoing phase of frozen rabies vaccine for humans.